Russian experts, together with pharmaceutical partners, are developing insulin tablets and long-acting drugs for the administration once a week. This was reported by the director of NMIC endocrinology Natalya Mokrysheva, RIA Novosti reports. According to her, the new drugs will enable more effective control of diabetes and significantly reduce the limitations in the patients' daily lives.